Close Menu

NEW YORK (GenomeWeb) – Thermo Fisher Scientific on Thursday reported a 5 percent increase in fourth quarter and full-year 2019 revenues.

The Waltham, Massachusetts-based company had Q4 revenues of $6.83 billion, up from $6.51 billion in Q4 2018 and beating the consensus analyst estimate of $6.78 billion. Organic revenue also grew 5 percent, while acquisitions drove revenue up by 1 percent and currency effects decreased revenue by 1 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to NPR, an antibody-based test could identify people who were exposed to SARS-CoV-2 and either didn't develop symptoms or were misdiagnosed.

Ars Technica reports that a multicellular eukaryotic parasite has lost its mitochondria.

In Science this week: perspective piece says AI can accelerate drug discovery by using genomic and chemical data, and more.

A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.